NCT03775915

Brief Summary

Real-time neurofeedback aims to alter brain activation patterns through online feedback of ongoing brain activity using magnetic resonance imagining (MRI). Stroke survivors will be randomised to receive 3 sessions of real or sham neurofeedback. This study aims to investigate whether: 1) stroke survivors can maintain alterations in brain activity after the feedback is removed, 2) neurofeedback training leads to improvements in movement of the hand and arm, 3) neurofeedback training leads to changes in brain structure and function, 4) variability in response across people can be understood.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 9, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 14, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2020

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

August 13, 2021

Completed
Last Updated

June 13, 2023

Status Verified

July 1, 2020

Enrollment Period

2.1 years

First QC Date

December 6, 2018

Results QC Date

June 11, 2021

Last Update Submit

May 16, 2023

Conditions

Keywords

Motor functionBrain activity

Outcome Measures

Primary Outcomes (2)

  • Lateralisation of Brain Activity

    Lateralisation of brain activity during movement of the affected hand, assessed using functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal. The activation in the region of interest is calculated for each hemisphere and the laterality index calculated as: (ipsilesional hemisphere - contralesional hemisphere) / (ipsilesional hemisphere + contralesional hemisphere). As such, positive values are indicative of greater activation in the ipsilesional hemisphere.

    Throughout the 3 intervention sessions, an average of 4 days

  • Hand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)

    Performance on the Jebsen Taylor hand function test (time, in seconds to complete specified activities reflecting daily living)

    Throughout study completion, 5 assessment sessions spread over approximately 3 weeks

Secondary Outcomes (11)

  • Change in Lateralisation of Brain Activity

    1 week follow up

  • Lateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)

    Baseline, 1 week follow up

  • Lateralisation of Brain Activity During Visuomotor Squeeze Task (EEG)

    Throughout study completion, an average of 3 weeks

  • Upper Limb Function

    Baseline, 1 week follow up

  • Change in Upper Limb Function

    1 month follow up

  • +6 more secondary outcomes

Other Outcomes (1)

  • Baseline Structure and Function as a Correlate of Response to Neurofeedback

    Throughout study completion, an average of 3 weeks.

Study Arms (2)

Real Neurofeedback

EXPERIMENTAL

3 sessions of Real Neurofeedback over 1 week

Other: Neurofeedback

Sham Neurofeedback

SHAM COMPARATOR

3 sessions of Sham Neurofeedback over 1 week

Other: Sham Neurofeedback

Interventions

A visual representation of the participants brain activity during movement of their affected hand in the MRI scanner.

Real Neurofeedback

A visual representation of brain activity pre-recorded from a previous participant

Sham Neurofeedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke \> 6 months previously
  • Unilateral upper limb impairment, but physically able to complete the tasks required

You may not qualify if:

  • Contraindications to MRI, such as a pacemaker, metallic implants or aneurysm clips
  • Inability to provide informed consent
  • Inability to actively participate in the research procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wellcome Centre for Integrative Neuroimaging (WIN)

Oxford, OX3 9DU, United Kingdom

Location

Related Publications (1)

  • Sanders ZB, Fleming MK, Smejka T, Marzolla MC, Zich C, Rieger SW, Luhrs M, Goebel R, Sampaio-Baptista C, Johansen-Berg H. Self-modulation of motor cortex activity after stroke: a randomized controlled trial. Brain. 2022 Oct 21;145(10):3391-3404. doi: 10.1093/brain/awac239.

MeSH Terms

Conditions

Stroke

Interventions

Neurofeedback

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Limitations and Caveats

Early termination due to COVID leading to smaller numbers enrolled in the study than originally planned. Interim analysis at the stopping point revealed results that were deemed unlikely to change with additional participants and so the study was closed and full analysis is in progress.

Results Point of Contact

Title
Dr Melanie Fleming, Research Associate
Organization
University of Oxford

Study Officials

  • Heidi Johansen-Berg, PhD

    University of Oxford

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly allocated (1:1 ratio) to either the intervention group (Real Neurofeedback) or the control group (Sham Neurofeedback). Randomisation is done after participants undergo baseline measurements using a computer-generated minimisation method that takes into account baseline upper limb function (Action Research Arm test score) and time since stroke.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2018

First Posted

December 14, 2018

Study Start

February 9, 2018

Primary Completion

March 20, 2020

Study Completion

March 20, 2020

Last Updated

June 13, 2023

Results First Posted

August 13, 2021

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

Anonymous data may be shared with other researchers on request

Shared Documents
ANALYTIC CODE
Time Frame
Analysis code may be shared following publication of the study results. There is no set end date for this
Access Criteria
Upon reasonable request to the PI

Locations